Skip to main content
Top
Published in: Breast Cancer Research 1/1999

Open Access 01-12-1999 | Research article

Cyclin D1expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat

Authors: James E Korkola, Geoffrey A Wood, Michael C Archer

Published in: Breast Cancer Research | Issue 1/1999

Login to get access

Abstract

Background

Resistance to mammary tumorigenesis in Copenhagen rats isassociated with loss of early preneoplastic lesions known as intraductalproliferations. The cause of this disappearance, however, is unknown.

Results

There were no differences in the numbers of lesions in mammarywhole-mounts prepared from Copenhagen or Wistar-Furth rats at 20 or 30 daysafter N-methyl-N-nitrosourea treatment, but at 37 days therewere significantly fewer lesions in Copenhagen glands. Furthermore, lesions inCopenhagen glands were exclusively intraductal proliferations, whereas inWistar-Furth glands more advanced lesions were also present.Immunohistochemical staining showed frequent cyclin D1 overexpression inWistar-Furth lesions at 37 days, but not in Copenhagen lesions. There were,however, no differences in p16 INK4a protein expression,bromodeoxyuridine labeling and apoptotic indices, or mast cell infiltrationbetween Copenhagen and Wistar-Furth lesions at any time.

Conclusions

Overexpression of cyclin D1 in preneoplastic lesionsmay be important in the development of mammary tumors in susceptible rats,although this overexpression does not appear to cause significant changes incell kinetics. Furthermore, the low levels of cyclin D1 expressionin Copenhagen intraductal proliferations may play a role in the resistance ofthese rats to mammary tumorigenesis.
Literature
1.
go back to reference Gould MN, Wang B, Moore CJ: Modulation of mammary carcinogenesis by enhancer and suppressor genes. In: Genes and Signal Transduction in Multistage Carcinogenesis.Edited by Colbrun NH. New York: Marcel Dekker,. 1989, 19-38. Gould MN, Wang B, Moore CJ: Modulation of mammary carcinogenesis by enhancer and suppressor genes. In: Genes and Signal Transduction in Multistage Carcinogenesis.Edited by Colbrun NH. New York: Marcel Dekker,. 1989, 19-38.
2.
go back to reference Isaacs JT: Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res. 1986, 46: 3958-3963.PubMed Isaacs JT: Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res. 1986, 46: 3958-3963.PubMed
3.
go back to reference Shepel LA, Lan H, Haag JD, et al: Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics. 1998, 149: 289-299.PubMedPubMedCentral Shepel LA, Lan H, Haag JD, et al: Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics. 1998, 149: 289-299.PubMedPubMedCentral
4.
go back to reference Korkola JE, Archer MC: Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions. Carcinogenesis. 1999, 20: 221-227. 10.1093/carcin/20.2.221.CrossRefPubMed Korkola JE, Archer MC: Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions. Carcinogenesis. 1999, 20: 221-227. 10.1093/carcin/20.2.221.CrossRefPubMed
5.
go back to reference Sukumar S, Notario V, Martin-Zanca D, Barbacid M: Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature. 1983, 306: 658-661.CrossRefPubMed Sukumar S, Notario V, Martin-Zanca D, Barbacid M: Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature. 1983, 306: 658-661.CrossRefPubMed
6.
go back to reference Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 1994, 79: 573-582.CrossRefPubMed Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 1994, 79: 573-582.CrossRefPubMed
7.
go back to reference Devilee P, Schuuring E, van de Vijver MJ, Cornelisse CJ: Recent developments in the molecular genetic understanding of breast cancer. Crit Rev Oncogen. 1994, 5: 247-70.CrossRef Devilee P, Schuuring E, van de Vijver MJ, Cornelisse CJ: Recent developments in the molecular genetic understanding of breast cancer. Crit Rev Oncogen. 1994, 5: 247-70.CrossRef
8.
go back to reference Sgambato A, Han EK, Zhang YJ, et al: Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis. 1995, 16: 2193-2198.CrossRefPubMed Sgambato A, Han EK, Zhang YJ, et al: Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis. 1995, 16: 2193-2198.CrossRefPubMed
9.
go back to reference Wang TC, Cardiff RD, Zuckerberg L, et al: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994, 369: 669-671. 10.1038/369669a0.CrossRefPubMed Wang TC, Cardiff RD, Zuckerberg L, et al: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994, 369: 669-671. 10.1038/369669a0.CrossRefPubMed
10.
go back to reference Weinstat-Saslow D, Merino MJ, Manrow RE, et al: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1995, 1: 1257-1260.CrossRefPubMed Weinstat-Saslow D, Merino MJ, Manrow RE, et al: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1995, 1: 1257-1260.CrossRefPubMed
11.
go back to reference Serrano M: The tumor suppressor protein p16 INK4a . Exp Cell Res. 1997, 237: 7-13. 10.1006/excr.1997.3824.CrossRefPubMed Serrano M: The tumor suppressor protein p16 INK4a . Exp Cell Res. 1997, 237: 7-13. 10.1006/excr.1997.3824.CrossRefPubMed
12.
go back to reference Russo IH, Russo J: Mammary gland neoplasia in long-term rodent studies. Env Health Perspect. 1996, 104: 938-967.CrossRef Russo IH, Russo J: Mammary gland neoplasia in long-term rodent studies. Env Health Perspect. 1996, 104: 938-967.CrossRef
13.
go back to reference Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F: Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 1998, 58: 2876-2880.PubMed Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F: Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 1998, 58: 2876-2880.PubMed
14.
go back to reference Emig R, Magener A, Ehemann V, et al: Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer . 1998, 78: 1661-1668.CrossRefPubMedPubMedCentral Emig R, Magener A, Ehemann V, et al: Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Br J Cancer . 1998, 78: 1661-1668.CrossRefPubMedPubMedCentral
15.
go back to reference Wood G, Korkola J, Lee V, Sarma D, Archer M: Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci. Carcinogenesis . 1997, 18: 1745-1750. 10.1093/carcin/18.9.1745.CrossRefPubMed Wood G, Korkola J, Lee V, Sarma D, Archer M: Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci. Carcinogenesis . 1997, 18: 1745-1750. 10.1093/carcin/18.9.1745.CrossRefPubMed
16.
17.
go back to reference Zhu Z, Jiang W, Thompson HJ: Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinogen. 1999, 24: 241-245. 10.1002/(SICI)1098-2744(199904)24:4<241::AID-MC1>3.0.CO;2-P.CrossRef Zhu Z, Jiang W, Thompson HJ: Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinogen. 1999, 24: 241-245. 10.1002/(SICI)1098-2744(199904)24:4<241::AID-MC1>3.0.CO;2-P.CrossRef
18.
go back to reference Russo J, Russo IH: Mammary tumorigenesis. In: Modification of Tumor Development in Rodents. 1991, 33: 175-191. Russo J, Russo IH: Mammary tumorigenesis. In: Modification of Tumor Development in Rodents. 1991, 33: 175-191.
19.
go back to reference Sandig V, Brand K, Herwig S, et al: Adenovirally transferred p16 INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nature Med. 1997, 3: 313-319.CrossRefPubMed Sandig V, Brand K, Herwig S, et al: Adenovirally transferred p16 INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nature Med. 1997, 3: 313-319.CrossRefPubMed
20.
go back to reference Bartek J, Bartkova J, Lukas J: The retinoblastoma pathway in cell cycle control and cancer. Exp Cell Res. 1997, 277: 1-6. 10.1006/excr.1997.3776.CrossRef Bartek J, Bartkova J, Lukas J: The retinoblastoma pathway in cell cycle control and cancer. Exp Cell Res. 1997, 277: 1-6. 10.1006/excr.1997.3776.CrossRef
21.
go back to reference Steeg PS, Zhou Q: Cyclins and breast cancer. Breast Cancer Res Treat. 1998, 52: 17-28. 10.1023/A:1006102916060.CrossRefPubMed Steeg PS, Zhou Q: Cyclins and breast cancer. Breast Cancer Res Treat. 1998, 52: 17-28. 10.1023/A:1006102916060.CrossRefPubMed
22.
go back to reference Russo J, Russo IH: Experimentally induced mammary tumors in rats. Breast Cancer Res Treat. 1996, 39: 7-20.CrossRefPubMed Russo J, Russo IH: Experimentally induced mammary tumors in rats. Breast Cancer Res Treat. 1996, 39: 7-20.CrossRefPubMed
23.
go back to reference Filmus J, Robles AI, Shi W, et al: Induction of cyclin D1 overexpression by activated ras. Oncogene. 1994, 9: 3627-3633.PubMed Filmus J, Robles AI, Shi W, et al: Induction of cyclin D1 overexpression by activated ras. Oncogene. 1994, 9: 3627-3633.PubMed
24.
go back to reference Aktas H, Cai H, Cooper GM: Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27KIP1. Mol Cell Bio. 1997, 17: 3850-3857.CrossRef Aktas H, Cai H, Cooper GM: Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27KIP1. Mol Cell Bio. 1997, 17: 3850-3857.CrossRef
25.
go back to reference Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999, 398: 422-426. 10.1038/18884.CrossRefPubMed Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999, 398: 422-426. 10.1038/18884.CrossRefPubMed
Metadata
Title
Cyclin D1expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat
Authors
James E Korkola
Geoffrey A Wood
Michael C Archer
Publication date
01-12-1999
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/1999
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr18

Other articles of this Issue 1/1999

Breast Cancer Research 1/1999 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine